Publications
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Alemtuzumab in multiple sclerosis treatment2015 | Second Faculty of Medicine
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | Second Faculty of Medicine
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis2010 | Second Faculty of Medicine
- Assessment of IgG and IgM antibodies in cerebrospinal fluid cells by the immunocytochemical method2001 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Prevalence of neurodegenerative/demyelinating disorders in patients with achalasia2022 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Physical Education and Sport
- Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry2022 | Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis2022 | Second Faculty of Medicine
- Breastfeeding and multiple sclerosis2022 | Second Faculty of Medicine
Loading network view...